| 2.9757 0.066 (2.26%) | 05-21 12:30 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.77 | 1-year : | 4.08 |
| Resists | First : | 3.23 | Second : | 3.5 |
| Pivot price | 2.98  |
|||
| Supports | First : | 2.79 | Second : | 2.32 |
| MAs | MA(5) : | 2.95 |
MA(20) : | 3.02 |
| MA(100) : | 3.22 |
MA(250) : | 5.83 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 21.7 |
D(3) : | 21.5 |
| RSI | RSI(14): 47.6 |
|||
| 52-week | High : | 25 | Low : | 0.94 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CDT ] has closed above bottom band by 47.9%. Bollinger Bands are 70% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 42 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.98 - 2.99 | 2.99 - 3 |
| Low: | 2.85 - 2.87 | 2.87 - 2.89 |
| Close: | 2.88 - 2.91 | 2.91 - 2.94 |
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Mon, 11 Mar 2024
Conduit Pharmaceuticals Opens New Laboratory in UK - Yahoo Finance
Wed, 14 Feb 2024
Private equity firms among Conduit Pharmaceuticals Inc.'s (NASDAQ:CDT) largest shareholders, saw gain in holdings ... - Yahoo Finance
Mon, 18 Dec 2023
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day ... - Markets Insider
Mon, 30 Oct 2023
Conduit Pharma (NASDAQ: CDT), that disaster of a despac, up 80% on speculation - Dhaka Tribune
Mon, 30 Oct 2023
Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today? - InvestorPlace
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 74 (M) |
| Shares Float | 19 (M) |
| Held by Insiders | 86.6 (%) |
| Held by Institutions | 1.9 (%) |
| Shares Short | 42 (K) |
| Shares Short P.Month | 55 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.01 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -91 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -33.07 |
| PEG Ratio | 0 |
| Price to Book value | -297.58 |
| Price to Sales | 0 |
| Price to Cash Flow | -28.46 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|